Loading market data...
Latest Top News
Pharma Growth Story: Bliss GVS Reports Strong December-Quarter Earnings with ₹232.7 Million Profit
Bliss GVS Pharma Ltd posted consolidated revenue of ₹2.18 billion and net profit of ₹232.7 million for the December 2025 quarter. The results highlight steady demand for pharmaceutical products, operational efficiency, and resilience in a competitive market, reinforcing the company’s position in India’s healthcare and pharma industry.
Stay Ahead – Explore Now! Prism Secures ₹885 Crore Tax Relief Ahead of Planned IPO






